Legal & General Group
DFTX

Legal & General Group’s Definium Therapeutics DFTX Stock Holding History

Legal & General Group’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.48M Buy
74,004
+14,205
+24% +$351K ﹤0.01% 1743
2026
Q1 		$1.13M Sell
59,799
-7,176
-11% -$122K ﹤0.01% 2100
2025
Q4 		$897K Buy
66,975
+11,956
+22% +$148K ﹤0.01% 2249
2025
Q3 		$649K Sell
55,019
-1,684
-3% -$15.7K ﹤0.01% 2369
2025
Q2 		$368K Sell
56,703
-590
-1% -$3.88K ﹤0.01% 2525
2025
Q1 		$335K Sell
57,293
-1,144
-2% -$8.19K ﹤0.01% 2519
2024
Q4 		$407K Buy
58,437
+762
+1% +$5.24K ﹤0.01% 2533
2024
Q3 		$328K Buy
57,675
+4,442
+8% +$30.9K ﹤0.01% 2588
2024
Q2 		$384K Buy
+53,233
New +$466K ﹤0.01% 2508
2023
Q1 		– Sell
-1,025
Closed -$2.25K – 3389
2022
Q4 		$2.25K Sell
1,025
-2,957
-74% -$8.21K ﹤0.01% 3390
2022
Q3 		$13K Buy
3,982
+989
+33% +$9.49K ﹤0.01% 3299
2022
Q2 		$29K Sell
2,993
-2,644
-47% -$33.5K ﹤0.01% 3122
2022
Q1 		$96K Buy
5,637
+2,004
+55% +$34.8K ﹤0.01% 2882
2021
Q4 		$78K Buy
3,633
+54
+2% +$1.72K ﹤0.01% 2956
2021
Q3 		$129K Buy
3,579
+137
+4% +$5.92K ﹤0.01% 2798
2021
Q2 		$182K Buy
+3,442
New +$181K ﹤0.01% 2558

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Legal & General Group's DFTX Position: Q2 2026 in Review

Legal & General Group increased its Definium Therapeutics (DFTX) stake by 24% in Q2 2026, buying an estimated $351K and bringing the position to 74,004 shares worth $3.48M. The position accounts for ﹤0.01% of the portfolio, ranked #1743.

Legal & General Group first reported a position in DFTX in Q2 2021 and has held it in 16 quarters since. 361 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Legal & General Group held 74,004 shares of Definium Therapeutics worth $3.48M as of Q2 2026.
  • Legal & General Group bought 14,205 Definium Therapeutics shares in Q2 2026, an estimated $351K.
  • Definium Therapeutics made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #1743 holding.
  • Legal & General Group first reported a position in Definium Therapeutics in Q2 2021 and has held it in 16 quarters since.
  • 361 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.